Lv71
5000 积分 2022-05-11 加入
Macrophages and fibroblasts as regulators of the immune response in pancreatic cancer
2小时前
已完结
Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study
11天前
已完结
Biomarker analysis from a phase II multi-institutional study of nivolumab in patients with advanced refractory biliary tract cancer
13天前
已完结
SWOG 1609 cohort 48: anti–CTLA‐4 and anti–PD‐1 for advanced gallbladder cancer
13天前
已完结
Dual checkpoint inhibition in gallbladder cancer: Bridging new hope with the need for biomarkers
13天前
已完结
Predictive value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis
18天前
已完结
Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials
21天前
已完结
Nectin-4 Expression Patterns and Therapeutics in Oncology
21天前
已完结
Oncolytic virus VG161 in refractory hepatocellular carcinoma
21天前
已完结
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial
1个月前
已完结
皖公网安备34019202002308
